Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AMG-531 increases platelet counts in immune thrombocytopenic purpura patients

Jan. 8, 2007

Medivir files to begin phase I trials of cathepsin K inhibitor MIV-701

Jan. 5, 2007

VGX-1027 active against diabetes in preclinical models

Jan. 4, 2007

Zydus launches Simvastatin Tablets

Jan. 4, 2007

BioGeneriX and Neose extend GlycoPEG-GCSF collaboration

Jan. 4, 2007

Novel antidiabetic agents claimed in recent patents

Jan. 3, 2007

WelChol filed for treatment of type 2 diabetes

Jan. 3, 2007

Authorized generic Oxandrin launched by Watson

Jan. 3, 2007

LibiGel studied for female sexual dysfunction in phase III trial

Jan. 3, 2007

Recent patents describe novel agents for metabolic disorders

Jan. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...